Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor-Reference-Cited by-同舟云学术

Pathogen acquisition in patients with cystic fibrosis receiving ivacaftor or lumacaftor/ivacaftor

Published:2019-04-22 Issue: Volume: Page:
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

Singh Sachinkumar B.¹,McLearn‐Montz Amanda J.¹,Milavetz Francesca²,Gates Levi K.²,Fox Christopher²,Murry Logan T.²,Sabus Ashley²,Porterfield Harry S.³,Fischer Anthony J.¹

Affiliation:

1. Stead Family Department of PediatricsUniversity of Iowa Carver College of MedicineIowa City Iowa

2. Department of Pharmacy Practice and ScienceUniversity of Iowa College of PharmacyIowa City Iowa

3. Department of PathologyUniversity of Iowa Carver College of MedicineIowa City Iowa

Funder

National Heart, Lung, and Blood Institute

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Cystic Fibrosis Foundation Therapeutics

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.24341

Reference40 articles.

1. Risk factors for bronchiectasis in children with cystic fibrosis;Sly PD;N Engl J Med,2013

2. Association between respiratory tract methicillin‐resistant Staphylococcus aureus and survival in cystic fibrosis;Dasenbrook EC;JAMA: the Journal of the American Medical Association,2010

3. Risk factors for mortality before age 18 years in cystic fibrosis;McColley SA;Pediatr Pulmonol,2017

4. A functional anatomic defect of the cystic fibrosis airway;Birket SE;Am J Respir Crit Care Med,2014

5. Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator‐knockout ferret lungs;Keiser NW;Am J Respir Cell Mol Biol,2015

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of Staphylococcus aureus in cystic fibrosis pathogenesis and clinico-microbiological interactions;Diagnostic Microbiology and Infectious Disease;2024-07

2. Antibiofilm Strategies in Neonatal and Pediatric Infections;Antibiotics;2024-05-30

3. Impact of lumacaftor/ivacaftor on the bacterial and fungal respiratory pathogens in cystic fibrosis: a prospective multicenter cohort study in Sweden;Therapeutic Advances in Respiratory Disease;2024-01

4. Ethnic differences in staphylococcus aureus acquisition in cystic fibrosis;Journal of Cystic Fibrosis;2023-09

5. Impact of elexacaftor–tezacaftor–ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis;Pediatric Pulmonology;2022-12-09